104 related articles for article (PubMed ID: 1280705)
1. Renal effects of alacepril in essential hypertension.
Tomita K; Nonoguchi H; Terada Y; Marumo F
J Cardiovasc Pharmacol; 1992 Oct; 20(4):520-4. PubMed ID: 1280705
[TBL] [Abstract][Full Text] [Related]
2. Effect of the novel orally active angiotensin converting enzyme inhibitor alacepril on cardiovascular system in experimental animals.
Takeyama K; Minato H; Nakatsuji K; Suzuki H; Nose I; Oka M; Hosoki K; Hatano N; Kadokawa T
Arzneimittelforschung; 1986; 36(1):69-73. PubMed ID: 3513779
[TBL] [Abstract][Full Text] [Related]
3. Racial differences in the renal response to blood pressure lowering during chronic angiotensin-converting enzyme inhibition: a prospective double-blind randomized comparison of fosinopril and lisinopril in older hypertensive patients with chronic renal insufficiency.
Mitchell HC; Smith RD; Cutler RE; Sica D; Videen J; Thompsen-Bell S; Jones K; Bradley-Guidry C; Toto RD
Am J Kidney Dis; 1997 Jun; 29(6):897-906. PubMed ID: 9186076
[TBL] [Abstract][Full Text] [Related]
4. Long-term plasma levels and dose modulation of alacepril in patients with chronic renal failure.
Nonoguchi H; Kiyama S; Kitamura K; Naruse M; Tomita M; Tazoe N; Tajiri M; Nakayama Y; Kohda Y; Inoue T; Tomita K
Hypertens Res; 2008 Jan; 31(1):29-36. PubMed ID: 18360015
[TBL] [Abstract][Full Text] [Related]
5. Mechanistic analysis of renal protection by angiotensin converting enzyme inhibitor in Dahl salt-sensitive rats.
Hirawa N; Uehara Y; Kawabata Y; Ohshima N; Ono H; Nagata T; Gomi T; Ikeda T; Goto A; Yagi S
J Hypertens; 1994 Aug; 12(8):909-18. PubMed ID: 7814850
[TBL] [Abstract][Full Text] [Related]
6. Effects of an angiotensin-converting enzyme inhibitor, alacepril, on cardiovascular and sympathetic nervous responses to mental stress in patients with essential hypertension.
Saitoh M; Miyakoda H; Kitamura H; Kinugawa T; Kotake H; Mashiba H
Intern Med; 1993 Sep; 32(9):691-4. PubMed ID: 8142672
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the effect of an angiotensin-converting enzyme inhibitor, alacepril, on drug-induced renin-angiotensin-aldosterone system activation in normal dogs.
Sakatani A; Miyagawa Y; Takemura N
J Vet Cardiol; 2016 Sep; 18(3):248-254. PubMed ID: 27364087
[TBL] [Abstract][Full Text] [Related]
8. Effect of alacepril on 24-hour blood pressure in elderly hypertensive patients.
Kohara K; Hara-Nakamura N; Takada Y; Iwata T; Ochi T; Kukita H; Muneta S; Hiwada K
Int J Clin Pharmacol Ther; 1996 Sep; 34(9):380-3. PubMed ID: 8880286
[TBL] [Abstract][Full Text] [Related]
9. Effect of alpha-adrenergic blockers, ACE inhibitors, and calcium channel antagonists on renal function in hypertensive non-insulin-dependent diabetic patients.
Giordano M; Sanders LR; Castellino P; Canessa ML; DeFronzo RA
Nephron; 1996; 72(3):447-53. PubMed ID: 8852495
[TBL] [Abstract][Full Text] [Related]
10. Effects of a long-term treatment with alacepril on left ventricular hypertrophy and function in patients with essential hypertension.
Sumimoto T; Ochi T; Hiwada K
J Clin Pharmacol; 1992 Jul; 32(7):667-70. PubMed ID: 1386375
[TBL] [Abstract][Full Text] [Related]
11. General pharmacology of the novel angiotensin converting enzyme inhibitor alacepril. 1st communication: Effects on cardiovascular, visceral and renal functions and on blood.
Matsuno Y; Taira N; Fujitani B; Ito T; Kadokawa T
Arzneimittelforschung; 1986; 36(1):55-62. PubMed ID: 3513777
[TBL] [Abstract][Full Text] [Related]
12. Effect of antihypertensive treatment with alacepril on insulin resistance in diabetic spontaneously hypertensive rats.
Sato T; Nara Y; Kato Y; Yamori Y
Metabolism; 1996 Apr; 45(4):457-62. PubMed ID: 8609831
[TBL] [Abstract][Full Text] [Related]
13. Tissue levels, tissue angiotensin converting enzyme inhibition and antihypertensive effect of the novel antihypertensive agent alacepril in renal hypertensive rats.
Nambu K; Matsumoto K; Takeyama K; Hosoki K; Miyazaki H; Hashimoto M
Arzneimittelforschung; 1986; 36(1):47-51. PubMed ID: 3006710
[TBL] [Abstract][Full Text] [Related]
14. Antihypertensive activity of alacepril, an orally active angiotensin converting enzyme inhibitor, in renal hypertensive rats and dogs.
Takeyama K; Minato H; Fukuya F; Kawahara S; Hosoki K; Kadokawa T
Arzneimittelforschung; 1985; 35(10):1502-7. PubMed ID: 3000389
[TBL] [Abstract][Full Text] [Related]
15. Effects of alacepril and amlodipine on the renal injury induced by a high-cholesterol diet in rats.
Atarashi K; Takagi M; Minami M; Ishiyama A
J Hypertens; 1999 Dec; 17(12 Pt 2):1983-6. PubMed ID: 10703899
[TBL] [Abstract][Full Text] [Related]
16. Antihypertensive activity of alacepril in spontaneously hypertensive rats and deoxycorticosterone acetate-salt hypertensive rats and dogs.
Takeyama K; Minato H; Fukuya F; Kawahara S; Hosoki K; Kadokawa T
Arzneimittelforschung; 1985; 35(10):1507-12. PubMed ID: 3000390
[TBL] [Abstract][Full Text] [Related]
17. Acute effects of the new oral angiotensin converting enzyme inhibitor 1-(D-3-acetylthio-2-methylpropanoyl)-L-prolyl-L-phenylalanine (Alacepril) in essential hypertension.
Mizuno K; Hashimoto S; Kunii N; Tani M; Niimura S; Yabe R; Watari H; Fukuchi S
Res Commun Chem Pathol Pharmacol; 1985 Aug; 49(2):175-87. PubMed ID: 2997886
[TBL] [Abstract][Full Text] [Related]
18. Effects of angiotensin-converting enzyme inhibition on altered renal hemodynamics induced by low protein diet in the rat.
Fernández-Repollet E; Tapia E; MartÃnez-Maldonado M
J Clin Invest; 1987 Oct; 80(4):1045-9. PubMed ID: 3308957
[TBL] [Abstract][Full Text] [Related]
19. Effects of the angiotensin converting enzyme inhibitors captopril, rentiapril, and alacepril in patients with essential and renovascular hypertension.
Ideishi M; Sasaguri M; Ikeda M; Arakawa K
Clin Ther; 1989; 11(4):441-51. PubMed ID: 2550133
[TBL] [Abstract][Full Text] [Related]
20. Effect of alacepril on blood pressure and neurohumoral factors at rest and during dynamic exercise in patients with essential hypertension.
Kinugawa T; Kitamura H; Ogino K; Noguchi N; Matsumoto T; Hisatome I; Miyakoda H; Kotake H; Mashiba H
Br J Clin Pharmacol; 1992 Oct; 34(4):366-9. PubMed ID: 1457272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
